TCT 283: Clinical Outcomes of Patients Receiving IABP From the Cardiogenic Shock Working Group: A Comparison of Heart Failure and Myocardial Infarction Related Cardiogenic Shock

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; NuPulseCV; Getinge; Boston Scientific Corporation